Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Alzamend Neuro, Inc. (ALZN) had Cash Flow from Financial Activities of $4.83M for the most recently reported fiscal year, ending 2026-04-30.
| Income Statement Financials | |
-- |
|
$-8.77M |
|
-- |
|
-- |
|
$8.77M |
|
$-8.77M |
|
$-0.01M |
|
$-8.77M |
|
$-8.77M |
|
$-8.77M |
|
$-8.77M |
|
$-8.77M |
|
$-8.77M |
|
$-8.77M |
|
$-8.66M |
|
3.34M |
|
3.34M |
|
$-2.63 |
|
$-2.63 |
|
| Balance Sheet Financials | |
$1.76M |
|
$0.31M |
|
$0.31M |
|
$2.08M |
|
$1.35M |
|
-- |
|
-- |
|
$1.35M |
|
$0.73M |
|
$0.73M |
|
$0.73M |
|
4.26M |
|
| Cash Flow Statement Financials | |
$-8.07M |
|
-- |
|
|
Cash Flow from Financial Activities |
$4.83M |
$3.95M |
|
$0.71M |
|
$-3.24M |
|
$0.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1196.43% |
|
-1196.43% |
|
-421.88% |
|
-1196.43% |
|
$0.17 |
|
$-2.42 |
|
$-2.42 |
|